New Approach Attacks 'Undruggable' Cancers from the Outside In
Researchers at UCSF have found a way to attack one of the most common drivers of lung, colorectal, and pancreatic cancer by targeting the proteins it produces on the outside of the cell.
University of California San Francisco
Give to UCSF
Bo Huang Delivers 2018 Byers Award Lecture on Boundary-Pushing Microscopy
Huang highlighted the microscopy work in his lab that has enabled a clearer understanding of the function of cells and the processes that underlie disease.
3 UCSF Researchers Named 2017 Fellows of the American Association for the Advancement of Science
Three UC San Francisco researchers have been selected as fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of Science and three other peer-reviewed journals.
Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One
Scientists from two U.S. national laboratories, industry, and academia on Oct. 27 launched an unprecedented effort to transform the way cancer drugs are discovered.
UCSF Specialties Among World’s Best in US News Global Universities Rankings for 2018
UCSF has ranked in the top 10 for seven specialties in 2017 Best Global Universities rankings released Tuesday by U.S. News & World Report.
Researchers to Combat Drug-Resistant Lung Cancer at New NCI-Funded Center at UCSF
The NCI has announced that UCSF will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016.
Key Psychiatric Drug Target Comes Into Focus
Researchers at UC San Francisco, the University of North Carolina-Chapel Hill, and Stanford University report a major step toward designing more powerful psychiatric drugs with fewer side effects.
Innovative Type 1 Diabetes Approach Licensed to Encellin
Encellin obtained exclusive rights from UCSF for a proprietary cell encapsulation technology aimed at improving physicians’ ability to perform cell transplants without the need for immunosuppressive drugs.
Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis
UCSF scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic MS.
Common Use of Antibiotics in Cells Grown for Research Could Distort Tests
A new study by UCSF researchers raises a red flag against adding antibiotics when growing cells in labs, finding that it can induce unintentional genetic changes in the cells and distort test results.
